Get the Weekly Intelligence Brief — top committee picks every Sunday.

HSIC vs OMDA

Henry Schein vs Omada Health — AI-powered side-by-side comparison
HSIC
Henry Schein
67
Buy
VS
OMDA
Omada Health
59
Buy
MetricHSICOMDA
AI Score 67 59
Price $89.16 $24.00
P/E Ratio 25.77× 353.61×
ROE 12.3% -5.6%
Revenue Growth YoY
Gross Margin 30.3% 68.2%
Debt / Equity 1.21× 0.00×
Dividend Yield 0.0% 0.0%
RSI (14) 59.4 66.6
Beta 0.808 1.7204
Expected Upside +0.8%

AI Committee View

Current Innellis committee reasoning for HSIC versus OMDA.
HSIC leads by 8 points.

HSIC scores 67/100 (Buy) versus OMDA at 59/100 (Buy).

HSIC Committee View
75% agreement
4 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.

Bull Case
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
OMDA Committee View
50% agreement
4 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 35.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
  • Bollinger bandwidth of 35.5% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
HSIC Full Analysis OMDA Full Analysis